Friday, October 27, 2017

Endo Sues FDA Over 503(B) Compounding Policy

Inside Health Policy-1 hour ago
Endo Pharmaceuticals and subsidy Par Sterile Products are suing FDA to block the agency's current interim policy on compounding of bulk substances by ...

No comments: